GRACE SPENCER: Open Payments
NPI 1285158170 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 56 payments from 18 companies in 2025. Trend: 2023 $446 · 2024 $1,866 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $245 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $239 |
| Lilly USA, LLC | 10 | $208 |
| Radius Health, Inc. | 1 | $128 |
| Tandem Diabetes Care, Inc. | 6 | $121 |
| Medtronic, Inc. | 2 | $112 |
| BETA BIONICS, INC. | 5 | $93 |
| Dexcom, Inc. | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| SANOFI-AVENTIS U.S. LLC | 4 | $65 |
Products named: Kerendia, JARDIANCE, Tymlos, t:slim X2 Insulin Pump with Control-IQ, Wegovy, MINIMED 780G, Rybelsus, iLet Bionic Pancreas.
Industry payments across AL — which companies pay providers there.
